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Abstract
Objective: To describe national, state-specific, and sociodemographic trends in diagnoses of 
depressive disorders recorded during delivery hospitalizations.
Methods: Data were analyzed from the National Inpatient Sample (2000–2015) and 31 
publically available State Inpatient Databases (2000–2015) of the Healthcare Cost and Utilization 
Project. Delivery Hospitalizations were identified by using International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic and procedure codes for 
obstetric delivery. Depressive disorders were identified from ICD-9-CM diagnoses codes classified 
as depressive disorders in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition 
(291.89, 292.84, 293.83, 296.2–296.26, 296.3–296.36, 300.4, and 311). Prevalence rates and 
average annual rate change were calculated nationally and across 28 states with at least 3 years of 
data and age, payer source, and race or ethnicity.
Results: The U.S. rate of depressive disorders recorded during delivery hospitalizations 
increased from 4.1 diagnoses per 1,000 hospitalizations in 2000 to 28.7 in 2015. Rates 
significantly increased in 27 of the 28 states. Recent (2014–2015) rates were lowest in Hawaii and 
Nevada (<14/1,000) and highest in Vermont, Minnesota, Oregon, and Wisconsin (>49/1,000). 
Rates in 2015 were highest among those aged 35 years or older, public insurance recipients, and 
non-Hispanic white women (>31/1,000). The highest annual rate increases were in Vermont and 
Maine (≥3.8/1,000). Non-Hispanic white women, those ≥ 35 years of age, and public insurance 
recipients showed the highest annual rate increases during 2000–2015 (≥1.7 per 1,000).
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Conclusion: During 2000–2015, rates of depressive disorders recorded during delivery 
hospitalizations increased nationally, in 27 states with available data, and across all 
sociodemographic categories.
Precis
From 2000–2015, rates of depressive disorders recorded during delivery hospitalizations increased 
nationally across age, insurance, and race or ethnicity categories.
Introduction
Depression is one of the most common disorders during pregnancy and the postpartum 
period, with a prevalence ranging from 8.5%–12.9%.1,2 Depression during pregnancy is 
associated with an increased risk of poor maternal self-care, inadequate nutrition,3 obstetric 
complications,4–6 preterm labor,4,6,7 substance use,8 lower initiation and duration of 
breastfeeding,9 poor maternal-fetal attachment,10 and postpartum and chronic depression.11 
Maternal depression can affect a child’s mental and motor development, temperament, self-
regulation, self-esteem, and behavior;12 these detrimental effects can last into adolescence.
13,14
 In extreme cases, depression during pregnancy and the postpartum period can 
contribute to maternal mortality.15
There is growing recognition that maternal mental health is an important issue. The 21st 
Century Cures Act of 2016 authorized appropriations for federal grants to establish, expand, 
or maintain culturally competent state-based programs to screen and treat women who are 
pregnant or postpartum with depression.16 Given this recent focus, it is important to 
establish a baseline trend of depressive disorder diagnoses amongst pregnant women, prior 
to this legislation. Whether U.S. rates of depressive disorders recorded during delivery 
hospitalization have changed over time, or whether they vary by state or sociodemographic 
characteristics, has not been documented previously. Of population-based studies examining 
race or ethnicity and self-report depressive symptoms during pregnancy, results are 
inconclusive.17,18 Thus, we aim to describe U.S. rates of depressive disorders recorded 
during delivery hospitalizations, and also how patterns differ by state and socioeconomic 
factors, such as age, race or ethnicity, and type of insurance, from 2000 to 2015.
Methods
Data were analyzed from the National Inpatient Sample (2000–2015) and the State Inpatient 
Databases (2000–2015) of the Healthcare Cost and Utilization Project, Agency for 
Healthcare Research and Quality from 2000 through the third quarter of 2015.19 The fourth 
quarter of 2015 is excluded because of the transition to the International Classification of 
Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) Codes. The Healthcare Cost 
and Utilization Project contains the largest collection of longitudinal hospital care data 
derived from administrative data. The database includes all listed diagnoses and procedures, 
discharge status, patient demographics, and charges for all patients, regardless of payer. 
These data are frequently used to document mental health diagnoses20,21 and have 
undergone quality control measures.19 The National Inpatient Sample was used for all 
national analyses, including those by sociodemographic factors. This dataset approximates a 
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20% stratified sample of all patients discharged from U.S. community hospitals. Survey-
specific analysis techniques were used to account for clustering, stratification, and 
weighting, making the National Inpatient Sample nationally representative. The State 
Inpatient Databases were used for all state-specific analyses. This dataset includes census 
data from states that agree to release public use data, which includes 31 states in this 
analysis. No survey-specific analysis techniques are required when using the State Inpatient 
Databases.
The analytical sample of interest, delivery hospitalizations, was identified from the 2000–
2015 data files by using International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) diagnostic and procedure codes pertaining to obstetric delivery.22 
The outcome of interest, depressive disorder, was identified from ICD-9-CM diagnoses 
codes classified as depressive disorders in the Diagnostic and Statistical Manual of Mental 
Disorders, 5th Edition (Substance or Medication-Induced Depressive Disorder: 291.89, 
292.84, Depressive Disorder Due to Another Medical Condition: 293.83, Major Depressive 
Disorder, single or recurrent episode: 296.2–296.26, 296.3–296.36, Persistent Depressive 
Disorder [Dysthymia]: 300.4, and Other Specified or Unspecified Depressive Disorder: 
311). Premenstrual Dysphoric Disorder (625.4) was not included given our sample of 
interest, delivery hospitalizations.23 Given the nature of hospital discharge data, we were 
unable to identify what screening methods or assessments were used to identify these 
depressive disorders. Other covariates of interest were sociodemographic factors like age, 
payer source, and race or ethnicity. For payer source, ‘public’ includes Medicaid and 
Medicare, although Medicare recipients made up less than 2% of this category, and ‘other’ 
includes Worker’s Compensation, Tricare, Title V, and other government programs.19
National and state-specific prevalence rates and 95% confidence intervals of depressive 
disorders recorded per 1,000 delivery hospitalizations during 2000–2015 were calculated for 
each year nationally and across sociodemographic factors (age, payer source, and race or 
ethnicity) and states. Joinpoint version 4.6 was used to select linear models, by way of 
permutation tests, to determine the average annual rate change over the study period. For this 
analysis, we did not allow for any joinpoints, or change in trends, between years. Average 
annual rate changes were only calculated for the 27 states with at least 3 years of data and 
significant linear trends. A statistically significant change indicates that the annual rate 
change is different from zero, or that the trend is significantly decreasing or increasing over 
time. Joinpoint was also used to perform pairwise comparisons to determine whether trends 
significantly differed across categories of each sociodemographic factor. P-values less than 
0.05 were considered statistically significant. Institutional Review Board approval was not 
needed as this analysis was not considered human subjects research because of the use of 
publically available de-identified data.
Results
Analyses using the National Inpatient Sample revealed that U.S. rates of depressive 
disorders recorded during delivery hospitalizations increased from 4.1 diagnoses per 1,000 
delivery hospitalizations in 2000 to 28.7 in 2015 (Figure 1; Table 1). This represents a 7-fold 
increase in the rate and an average rate increase of 1.6/1,000 each year during 2000 to 2015. 
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State-specific analyses using the State Inpatient Databases revealed that rates of depressive 
disorders recorded during delivery hospitalizations varied by state (Table 2; Appendix 1 
[Appendix 1 is available online at http://links.lww.com/xxx]); 2014–2015 diagnosis rates 
were lowest in Hawaii and Nevada (<14/1,000) and highest in Vermont, Minnesota, 
Wisconsin, and Oregon (>49/1,000). During the study period, there were significant 
increases in the rate of depressive disorders recorded during delivery hospitalizations for 27 
of the 28 states with at least 3 years of data. Georgia was the only state where a linear trend 
was not significantly fit for the data (P = 0.4). Rates increased the slowest in Hawaii and 
Nevada with average increases of 0.7/1,000 each year. Rates increased the fastest in Vermont 
and Maine, both of which showed average increases of at least 3.8/1,000 each year (Figure 
2).
Additional analyses using the National Inpatient Sample revealed that rates of depressive 
disorders recorded during delivery hospitalizations varied across age, payer source, and race 
or ethnicity, but increased significantly among all groups. Rates in 2000 ranged from 3.4 per 
1,000 among women aged 19–24 years to 5.9 among women aged 35 years or older. Rates in 
2015 ranged from 27.1 per 1,000 among women aged 18 years or younger to 34.2 among 
women aged 35 years or older (Figure 3). Rates increased the fastest during 2000–2015 
among women aged 35 years and older (1.8/1,000 per year), and pairwise comparisons 
showed that the annual rate increases were significantly different amongst all age groups 
(P’s < 0.05). Rates in 2000 ranged from 2.8 per 1,000 among self-paying women to 4.7 
among publicly insured deliveries. Rates in 2015 ranged from 14.3 per 1,000 among self-
paying women to 31.4 among publically insured deliveries (Figure 3). Rates increased the 
fastest during 2000–2015 among publically insured deliveries (1.7/1,000 per year), and 
pairwise comparisons showed that the annual rate increases were significantly different 
between public and private and between self-pay and all other groups (P’s <0.05; Figure 3). 
By race or ethnicity, rates in 2000 ranged from 0.8 per 1,000 among Asian or Pacific 
Islander women to 5.6 among non-Hispanic white women. Rates in 2015 ranged from 8.8 
per 1,000 among Asian or Pacific Islander women to 37.2 among non-Hispanic white 
women (Figure 3). Rates increased the fastest over time among non-Hispanic white women 
(2.0/1,000 per year), and pairwise comparisons showed that the annual rate increases were 
significantly different amongst all race and ethnicity groups. (P’s <0.05; Figure 3).
Discussion
Results from this report show that national rates of depressive disorders recorded during 
delivery hospitalizations increased significantly from 4.1 per 1,000 hospitalizations in 2000 
to 28.7 in 2015, an average increase of 1.6 diagnoses per 1,000 each year. The most recent 
systematic reviews estimating the national prevalence of depression during pregnancy date 
back to 2005;1,2 the current report provides the most updated estimates available for 
depressive disorder recorded at delivery hospitalization. Among the 28 states with at least 3 
years of data, 27 showed significant increases in rates of depressive disorders recorded 
during delivery hospitalizations during 2000–2015. Recent rates (2015) were highest in 
deliveries to women identified as 35 years or older, publically insured, and non-Hispanic 
white. Consistent with the literature,18 women receiving public insurance during pregnancy 
showed the highest rates of depression diagnoses at delivery. This finding is also consistent 
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with the United States Preventive Services Task Force’s acknowledgement of lower 
socioeconomic status as a risk factor for depression.24 Because screening and diagnosing 
practices may differ by sociodemographic factors, differences in rates across these factors 
may reflect variability in identification of depression, rather than inherent risk of depression. 
For example, non-Hispanic white women are more likely to be screened for depression at 
delivery than non-Hispanic Black women,25 potentially inflating rates of depression 
amongst non-Hispanic white women.
Increasing trends in depressive disorders recorded during delivery hospitalization in this 
report may help to explain previously documented decreasing rates of self-reported 
postpartum depressive symptoms from 2004 to 2012.17 Increasing diagnoses at delivery 
from 2000 to 2015 may have resulted in an increase in treatment during the postpartum 
period and, in turn, a decrease in self-reported postpartum depressive symptoms. In many 
cases, pregnancy can be an opportunity for frequent care and monitoring by a health care 
provider, providing an ideal opportunity for the detection of depressive symptoms and if 
applicable, the documentation of a diagnosis, and the provision of treatment options through 
their clinic or referral.26 In the absence of active case identification strategies, most women 
with perinatal depression may neither seek nor receive help,27 thus, the American College of 
Obstetricians and Gynecologists, the United States Preventive Services Task Force’s, and 
The Council on Patient Safety in Women’s Health recommend universal screening for 
depression in pregnant and postpartum women.24,26,28 Given that screening is not 
universally practiced, depressive symptoms are commonly undiagnosed27,29 and our 
estimates are most likely underestimated.
This analysis documents baseline trends prior to 2016 legislation aimed at improving 
perinatal depression screening and treatment.16 State efforts to improve depression 
education and screening practices may be associated with differences in rates of diagnosed 
depressive disorders. A study of New Jersey data during 2009–2010 found that 
approximately 90% of women were screened for depression at delivery following a 2006 
mandate requiring depression screening at hospital delivery.25 However, this may not be the 
case in all states and the overall impact of legislation on perinatal depression treatment 
outcomes remains unclear.30 Increasing trends in this report could be a result of more cases, 
better recognition of depression, or improved diagnoses following screening and assessment. 
Future analyses documenting rates post-legislation and incorporating multiple data sources 
with varying forms of depression ascertainment would complement this analysis and allow 
for a better understanding of the burden of depression in pregnant women.
Results of our study are subject to several limitations. First, the nature of the data used 
affects the generalizability of the results. Data do not include deliveries outside of the 
hospital; however, those births represent only 1.5% of all US births.31 Not all hospitals 
participated; however, at least 80% of National Center for Health Statistics births are 
represented for each state. Not all states provided data to the public-use State Inpatient 
databases, and amongst those that did, not all had data for every year in the study period. 
Second, estimates are most likely underestimates because screening for depression is not 
universally practiced. In addition, because many women deliver without a prenatal care 
record,32 depressive disorders recorded in other points during the pregnancy may not be 
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documented on the delivery encounter for hospital discharge data. Third, analyses were 
dependent on ICD-CM coding, which may vary by hospital and state, and which may 
contribute to underestimated rates as ICD-CM codes are for billing and depressive disorders 
may not be documented. Depression screening and diagnosis are not typically included in 
reimbursed global obstetric payments, and providers may be less likely to document these 
ICD-CM codes because there is limited to no financial benefit from billing.33 We are also 
unable to determine what type of screener was used to identify and document the depressive 
disorders, so we are unable to comment on the sensitivity of these diagnoses. However, these 
data are frequently used to identify mental health diagnoses.20,21
Findings from this first state-based analysis of rates of depressive disorders recorded during 
hospitalization can help states understand the overall burden of depression among women at 
delivery. During 2000–2015, rates of depressive disorders recorded at delivery 
hospitalization increased significantly across the nation and in 27 states, and differed across 
age, insurance type, and race or ethnicity.
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Figure 1. 
U.S. national prevalence rate* and 95% confidence interval† of depressive disorders 
recorded per 1,000 hospitalizations Nationwide Inpatient Sample, Healthcare Cost and 
Utilization Project, 2000–−2015.‡ The solid blue line represents the prevalence rate and the 
dotted blue lines represent the 95% confidence intervals. *Prevalence rate numerator 
consisted of depressive disorder International Classification of Diseases-9-Clinical 
Modification codes (291.89, 292.84, 293.83, 296.2–296.26, 296.3–296.36, 300.4, and 311), 
prevalence rate denominator consisted of delivery hospitalization discharges. †Confidence 
intervals are based on unweighted data. ‡Rates are for 2000 through the third quarter of 
2015.
Haight et al. Page 9
Obstet Gynecol. Author manuscript; available in PMC 2020 November 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
A state-specific comparison of depressive disorders recorded per 1,000 delivery 
hospitalizations: (A) prevalence rate*, 2014–2015† and (B) average annual rate change, 
2000–2015. Data from state inpatient databases, Healthcare Cost and Utilization Project. 
Red line notes national value. *Prevalence rate numerator consisted of depressive disorder 
International Classification of Diseases-9-Clinical Modification codes (291.89, 292.84, 
293.83, 296.2–296.26, 296.3–296.36, 300.4, and 311), prevalence rate denominator 
consisted of delivery hospitalization discharges. †Rates for Arizona, Colorado, Iowa, 
Kentucky, Minnesota, Nebraska, North Carolina, and Wisconsin are 2015, the remainder are 
2014. ‡Significant at P<.05.
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Figure 3. 
Prevalence rates,* 95% confidence intervals,† and average annual percent change in the rate 
of depressive disorders recorded during delivery hospitalizations by sociodemographic 
characteristics: (A) age at admission, (B) payer source, and (C) race–ethnicity. Data from the 
Nationwide Inpatient Sample, Healthcare Cost and Utilization Project, 2000–2015.‡ Light 
blue bars indicate the year 2000; dark blue bars indicate the year 2015. *Prevalence rate 
numerator consisted of depressive disorder ICD-9-CM codes (291.89, 292.84, 293.83, 
296.2–296.26, 296.3–296.36, 300.4, and 311), prevalence rate denominator consisted of 
delivery hospitalization discharges. †Confidence intervals are based off of unweighted data. 
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‡Rates are for 2000 through the third quarter of 2015. §Includes Worker’s Compensation, 
Tricare, Title V, and other government programs. ¶Includes Medicaid and Medicare (<2%).
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Table 1.
National Case Counts and 95% Confidence Intervals (CI) of Depressive Disorders* Recorded at Delivery 
Hospitalization by Year; National Inpatient Database, Healthcare Cost and Utilization Project, 2000–2015
Year N (95% CI)
2000 16,055 (14,150 – 18,081)
2001 20,999 (18,843 – 23,073)
2002 29,045 (25,488 – 32,258)
2003 37,919 (33,804 – 42,058)
2004 49,496 (44,493 – 54,698)
2005 56,306 (49,893 – 62,468)
2006 57,731 (51,626 – 63,603)
2007 68,080 (60,847 – 75,293)
2008 73,349 (66,858 – 79,825)
2009 69,650 (63,113 – 76,131)
2010 81,063 (73,613 – 88,485)
2011 81,044 (73,466 – 88,526)
2012 81,360 (77,964 – 84,743)
2013 88,375 (84,564 – 92,048)
2014 100,290 (96,182 – 104,165)
2015† 82,086 (78,654 – 85,518)
*Consists of depressive disorder ICD-9-CM codes (291.89, 292.84, 293.83, 296.2–296.26, 296.3–296.36, 300.4, and 311)
†Case counts are only for the first three quarters of 2015 and are not representative of the entire year
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Table 2.
Case Counts of Depressive Disorders* Recorded at Delivery Hospitalizations, by State and Year; State 
Inpatient Databases, Healthcare Cost and Utilization Project, 2000–2015
State 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15†
Arizona 218 324 495 686 887 962 1,067 1,058 1,236 1,225 1,333 1,436 1,440 1,564 1,676 1,299
Arkansas --- --- --- --- 204 316 449 404 372 522 505 516 549 650 740 ---
California 1,187 1,613 --- 2,748 3,463 4,037 4,241 4,757 5,058 5,400 6,171 6,817 --- --- --- ---
Colorado 307 553 825 976 1,245 1,444 1,582 1,706 1,930 2,033 2,092 2,242 1,940 2,092 2,321 1,891
D.C. --- --- --- --- --- --- --- --- --- --- --- --- --- 233 268 ---
Florida 559 845 1,110 1,438 1,926 2,052 2,352 2,479 2,642 2,742 2,815 2,874 2,807 2,943 3,422 ---
Georgia --- --- --- --- --- --- --- --- --- --- --- --- 1,658 1,594 1,893 ---
Hawaii 43 61 62 106 109 105 140 98 148 166 172 211 149 198 191 ---
Iowa 194 202 324 456 631 652 688 846 829 928 967 1,136 1,080 1,236 1,295 1,058
Kentucky 165 218 306 459 588 620 651 660 812 1,041 1,094 1,160 1,220 1,260 1,390 1,064
Maine 198 272 360 543 --- --- 576 685 709 763 692 647 690 --- --- ---
Maryland 352 559 816 992 1,380 1,624 1,961 2,158 2,216 2,295 2,554 2,617 2,662 2,735 3,060 ---
Massachusetts 772 909 1,200 1,454 1,649 1,765 1,956 2,185 2,088 2,360 2,603 2,856 2,661 2,822 --- ---
Michigan 636 772 1,148 1,387 1,825 2,404 2,615 2,710 2,982 3,154 3,233 3,388 3,352 3,928 4,333 ---
Minnesota --- --- --- --- --- --- --- --- --- --- --- --- --- --- 3,398 2,695
Mississippi --- --- --- --- --- --- --- --- --- --- 301 316 --- --- --- ---
Nebraska --- 134 218 337 293 293 361 418 527 597 605 648 553 726 775 657
Nevada --- --- 72 116 164 173 211 226 238 255 262 304 290 279 465 ---
New Jersey 340 385 562 746 897 1,023 1,249 1,746 2,051 1,815 1,887 1,752 1,605 1,821 1,917 ---
New Mexico --- --- --- --- --- --- --- --- 416 501 518 640 618 635 669 ---
New York 873 1,122 1,548 2,054 2,444 2,743 3,104 3,287 3,790 3,820 4,356 4,708 4,488 4,572 5,154 ---
North 
Carolina 503 707 1,009 1,432 1,736 1,883 2,181 2,152 2,284 2,462 2,589 2,716 2,802 3,223 4,061 3,385
Oregon 336 525 666 730 875 944 987 1,124 1,335 1,372 1,487 1,569 1,661 1,706 2,120 ---
Rhode Island --- --- 338 338 403 453 415 432 431 378 437 564 466 431 503 ---
South 
Carolina 183 235 360 495 595 630 674 733 968 1,138 1,358 1,395 1,361 1,469 ---
---
South Dakota --- --- --- --- --- --- --- 237 245 330 324 368 394 451 509 ---
Utah 234 348 567 716 883 876 932 1,114 1,346 1,578 1,503 1,595 1,555 1,798 1,856 ---
Vermont --- 52 51 69 111 156 186 290 249 265 313 277 301 400 421 ---
Washington 436 534 724 879 1,007 1,018 1,198 1,296 1,507 1,816 1,885 2,001 2,046 2,456 3,006 ---
West Virginia 101 151 175 233 272 340 406 452 403 439 456 418 544 591 631 ---
Wisconsin 505 650 862 1,258 1,566 1,759 1,998 2,257 2,325 2,396 2,613 2,709 2,517 2,755 3,147 2,501
--- Data not available
*Consists of depressive disorder ICD-9-CM codes (291.89, 292.84, 293.83, 296.2–296.26, 296.3–296.36, 300.4, and 311)
†Case counts shown are only for the first three quarters of 2015 and are not representative of the entire year
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